Obudanersen sodium is under clinical development by Ionis Pharmaceuticals and currently in Phase II for Angelman Syndrome.

CX-801 is under development for the treatment of metastatic solid tumors including metastatic melanoma, metastatic renal cell carcinoma (RCC) and head and neck squamous cell carcinoma (HNSCC). It is a ...

As the new year begins, individuals looking to improve their health might consider participating in clinical trials, ...

Objective To describe the incidence and characteristics of match and training injuries in the UK Vitality Netball Superleague ...

Federal Reserve Bank of San Francisco President Mary Daly and Federal Reserve Board Governor Adriana Kugler speak as they attend the American Economics Association's annual conference, in San ...

159 tolas of gold ornaments looted from the shop at Simanta Square in Dhaka’s Jigatola ...